Clinical Trial

A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors

Name: A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors — clinical trial record (NCT04685226)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A Multicenter, Nonrandomized, Open-Label Phase I/IIClinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients with Solid Tumors

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2020-12-22; most recent amendment 2025-08-26.

Trial Details

NCT Number	NCT04685226
Lead Sponsor	Beijing InnoCare Pharma Tech Co., Ltd.
Conditions	Solid Tumors
Enrollment	310 participants
Start Date	2020-09-27
Primary Completion	2028-01-25 (estimated)
Study Completion	2028-02-25 (estimated)
Updated on ClinicalTrials.gov	2025-09-02